{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T06:38:01Z","timestamp":1771569481237,"version":"3.50.1"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>There is currently no vaccine against Chagas disease (ChD), and the medications available confer multiple side effects. <jats:italic>Mycobacterium bovis<\/jats:italic> Bacillus Calmette\u2013Gu\u00e9rin (BCG) produces balanced Th1, Th2, and Th17 modulatory immune responses and has improved efficacy in controlling chronic infections through nonspecific immunity. We aimed to improve the response to infection by inducing a stronger immune response and greater protection against the parasite by trained immunity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>BALB\/c mice were immunized with BCG subcutaneously, and 60 days later, they were infected with <jats:italic>Trypanosoma cruzi<\/jats:italic> intraperitoneally. An evaluation of the progression of the disease from the acute to the chronic stage, analyzing various aspects such as parasitemia, survival, clinical status, and humoral and cellular immune response, as well as the appearance of visceral megas and the histopathological description of target organs, was performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Vaccination reduced parasitemia by 70%, and 100% survival was achieved in the acute stage; although the presentation of clinical signs was reduced, there was no increase in the antibody titer or in the differential production of the isotypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum cytokine production indicated a proinflammatory response in infected animals, while in those who received BCG, the response was balanced by inducing Th1\/Th2-type cytokines, with a better prognosis of the disease in the chronic stage.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1380049","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:47:21Z","timestamp":1710996441000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Mycobacterium bovis BCG as immunostimulating agent prevents the severe form of chronic experimental Chagas disease"],"prefix":"10.3389","volume":"15","author":[{"given":"Minerva","family":"Arce-Fonseca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce","family":"Mata-Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Aranda-Fraustro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Rosales-Encina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario Alberto","family":"Flores-Valdez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Rodr\u00edguez-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American trypanosomiasis (Chagas disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"B2","unstructured":"Factsheet: Chagas Disease in the Americas for Public Health Workers2022"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.32776\/revbiomed.v32i2.890","article-title":"Prevalencia y conocimientos de la enfermedad de Chagas en dos comunidades del sureste de M\u00e9xico","volume":"32","author":"Cruz-Alegr\u00eda","year":"2021","journal-title":"Rev BioMed"},{"key":"B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"B5","first-page":"6","article-title":"Enfermedad de Chagas en M\u00e9xico","volume":"59","author":"Salazar-Schettino","year":"2016","journal-title":"Rev Fac Med (M\u00e9x)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000599","article-title":"Chagas cardiomyopathy: an update of current clinical knowledge and management: a scientific statement from the American Heart Association","volume":"138","author":"Nunes","year":"2018","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165658","article-title":"Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control","volume":"1866","author":"Bivona","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10010057","article-title":"After 100 years of BCG immunization against tuberculosis, what is new and still outstanding for this vaccine","volume":"10","author":"Flores-Valdez","year":"2022","journal-title":"Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11010121","article-title":"Non-specific effects of Bacillus calmette-gu\u00e9rin: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Trunk","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"MGM2","DOI":"10.1128\/microbiolspec.MGM2-0028-2013","article-title":"BCG vaccines","volume":"2","author":"Tran","year":"2014","journal-title":"Microbiol Spectr"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity: implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.06.002","article-title":"Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria","volume":"25","author":"Dos Santos","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e148291","DOI":"10.1172\/JCI148291","article-title":"BCG turns 100: its nontraditional uses against viruses, cancer, and immunologic diseases","volume":"131","author":"Singh","year":"2021","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1084\/jem.178.1.197","article-title":"Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine","volume":"178","author":"Stover","year":"1993","journal-title":"J Exp Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/372552a0","article-title":"Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi","volume":"372","author":"Langermann","year":"1994","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00276-X","article-title":"Safety and immunogenicity of recombinant Bacille Calmette-Gu\u00e9rin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine","volume":"17","author":"Edelman","year":"1999","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8040736","article-title":"BCG as a vector for novel recombinant vaccines against infectious diseases and cancers","volume":"8","author":"Mustafa","year":"2020","journal-title":"Vaccines"},{"key":"B18","article-title":"BCG-induced resistance in Trypanosoma cruzi experimental infections","volume":"32","author":"Bertelli","year":"1981","journal-title":"Tropenmed Parasitol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.114.4.1424","article-title":"A vaccination procedure against Trypanosoma cruzi infection in mice by nonspecific immunization","volume":"114","author":"Ortiz-Ortiz","year":"1975","journal-title":"J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1084\/jem.142.2.299","article-title":"Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo","volume":"142","author":"Hoff","year":"1975","journal-title":"J Exp Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/0020-7519(75)90049-1","article-title":"The effect of BCG on the course of experimental Chagas' disease in mice","volume":"5","author":"Kuhn","year":"1975","journal-title":"Int J Parasitol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2307\/3280831","article-title":"Heterologous and specific immunization of mice against Trypanosoma cruzi","volume":"66","author":"Burgess","year":"1980","journal-title":"J Parasitol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-013-0326-x","article-title":"Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG","volume":"203","author":"Vicco","year":"2014","journal-title":"Med Microbiol Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftw109","article-title":"Antibody profiles induced by Trypanosoma cruzi in chagasic patients with previous or current exposure to mycobacteria","volume":"74","author":"Peverengo","year":"2016","journal-title":"Pathog Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","article-title":"Outcomes of controlled human malaria infection after BCG vaccination","volume":"10","author":"Walk","year":"2019","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(99)00426-0","article-title":"IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice","volume":"18","author":"Araujo","year":"2000","journal-title":"Vaccine"},{"key":"B28","article-title":"Estudio comparativo de dos m\u00e9todos para valoraci\u00f3n cuantitativa de la parasitemia por tripanosomas","volume":"5","author":"Urribarr\u00ed","year":"1974","journal-title":"KASMERA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1038\/s41598-021-91993-8","article-title":"Vaccination with BCG\u0394BCG1419c protects against pulmonary and extrapulmonary TB and is safer than BCG","volume":"11","author":"Aceves-S\u00e1nchez","year":"2021","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9110974","article-title":"Electrolyzed oxidizing water modulates the immune response in BALB\/c mice experimentally infected with Trypanosoma cruzi","volume":"9","author":"Rodr\u00edguez-Morales","year":"2020","journal-title":"Pathogens"},{"key":"B31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.vetimm.2009.01.004","article-title":"Development of chronic cardiomyopathy in canine Chagas disease correlates with high IFN-gamma, TNF-alpha, and low IL-10 production during the acute infection phase","volume":"130","author":"Guedes","year":"2009","journal-title":"Vet Immunol Immunopathol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8964085","article-title":"Recombinant enolase of Trypanosoma cruzi as a novel vaccine candidate against Chagas disease in a mouse model of acute infection","volume":"2018","author":"Arce-Fonseca","year":"2018","journal-title":"J Immunol Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0264-410x(98)00311-9","article-title":"Vaccination of mice with a combination of BCG and killed Leishmania promastigotes reduces acute Trypanosoma cruzi infection by promoting an IFN-gamma response","volume":"17","author":"Araujo","year":"1999","journal-title":"Vaccine"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060826","article-title":"Nitazoxanide: A drug repositioning compound with potential use in Chagas disease in a murine model","volume":"16","author":"Arce-Fonseca","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/890672","article-title":"Mexican Trypanosoma cruzi T. cruzi I strains with different degrees of virulence induce diverse humoral and cellular immune responses in a murine experimental infection model","volume":"2010","author":"Espinoza","year":"2010","journal-title":"J BioMed Biotechnol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/450389","article-title":"Exacerbated skeletal muscle inflammation and calcification in the acute phase of infection by Mexican Trypanosoma cruzi DTUI strain","volume":"2014","author":"Vizca\u00edno-Castillo","year":"2014","journal-title":"BioMed Res Int"},{"key":"B37","article-title":"Componentes glicosilados de la envoltura de Mycobacterium tuberculosis que intervienen en la patog\u00e9nesis de la tuberculosis","volume":"18","author":"Gorocica","year":"2005","journal-title":"Rev Inst Nal Resp Mex"},{"key":"B38","article-title":"Inmunomodu-ladores como terapia adyuvante en la enfermedad infecciosa","volume":"11","author":"Garc\u00eda-Hern\u00e1ndez","year":"2009","journal-title":"Medicina Universitaria"},{"key":"B39","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.32407\/RCON","article-title":"Pericarditis constructiva asociada a miocardiopat\u00eda chag\u00e1sica","volume":"33","author":"Wong","year":"2018","journal-title":"CONAREC"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051479","article-title":"Effectiveness of nitazoxanide and electrolyzed oxiding water in treating Chagas disease in a canine model","volume":"15","author":"Rodr\u00edguez-Morales","year":"2023","journal-title":"Pharmaceutics"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12663","article-title":"Myocardial fibrosis in Chagas disease and molecules related to fibrosis","volume":"41","author":"Chaves","year":"2019","journal-title":"Parasite Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2613.2001.00203.x","article-title":"TNF-alpha is expressed at sites of parasite and tissue destruction in the spleen of mice acutely infected with Trypanosoma cruzi","volume":"82","author":"Lima","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0120-5633(11)70193-0","article-title":"Enfermedad de Chagas","volume":"18","author":"Rosas","year":"2011","journal-title":"Rev Colomb Cardiol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2019.100507","article-title":"Chagas disease: chronic Chagas cardiomyopathy","volume":"46","author":"Echavarr\u00eda","year":"2021","journal-title":"Curr Probl Cardiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1182\/blood.2020008815","article-title":"Chagas disease initially diagnosed in a lymph node","volume":"136","author":"Verma","year":"2020","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-020117-043711","article-title":"Pathology and pathogenesis of Chagas heart disease","volume":"14","author":"Bonney","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1086\/653481","article-title":"Gene expression changes associated with myocarditis and fibrosis in hearts of mice with chronic chagasic cardiomyopathy","volume":"202","author":"Soares","year":"2010","journal-title":"J Infect Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"29","DOI":"10.6018\/analesbio.38.03","article-title":"Lesiones histol\u00f3gicas asociadas a la posible infecci\u00f3n por Trypanosoma cruzi (Chagas, 1909) en corazones de roedores sinantr\u00f3picos capturados en Yucat\u00e1n, M\u00e9xico","volume":"38","author":"Torres-Castro","year":"2016","journal-title":"Anales Biolog\u00eda"},{"key":"B50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7705\/biomedica.v39i3.4192","article-title":"Estudio histopatol\u00f3gico de tejido cardiaco de roedores infectados con Trypanosoma cruzi capturados en barrios suburbanos de M\u00e9rida, M\u00e9xico","volume":"39","author":"Ucan-Euan","year":"2019","journal-title":"Biom\u00e9dica"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.11.062","article-title":"Improved outcome of Trypanosoma cruzi infection in rats following treatment in early life with suspensions of heat-killed environmental Actinomycetales","volume":"25","author":"Fontanella","year":"2007","journal-title":"Vaccine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.2350-2357.2004","article-title":"Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease","volume":"72","author":"Marinho","year":"2004","journal-title":"Infect Immun"},{"key":"B53","volume-title":"Respuesta inmune en \u00f3rganos blanco infectados con cepas mexicanas de","author":"Vizca\u00edno-Castillo","year":"2007"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1380049\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T04:47:27Z","timestamp":1710996447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1380049\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2024.1380049"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1380049","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"article-number":"1380049"}}